CATALYST PHARMACEUTICALS, INC. financial data

Symbol
CPRX on Nasdaq
Location
Coral Gables, FL
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 05 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 616 % +32.9%
Quick Ratio 18.14 % -13%
Debt-to-equity 14.72 % -13.2%
Return On Equity 26.39 % +2.5%
Return On Assets 23 % +4.5%
Operating Margin 44.76 % +18.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 122,912,387 shares +3.1%
Common Stock, Shares, Outstanding 123,264,583 shares +3.4%
Entity Public Float 1,720,853,867 USD +28.3%
Common Stock, Value, Issued 123,000 USD +3.4%
Weighted Average Number of Shares Outstanding, Basic 122,600,730 shares +3.1%
Weighted Average Number of Shares Outstanding, Diluted 127,090,194 shares +1.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 578,196,000 USD +25.6%
Research and Development Expense 14,700,000 USD +35.8%
General and Administrative Expense 56,095,000 USD +0.3%
Operating Income (Loss) 258,775,000 USD +48.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 285,795,000 USD +51.4%
Income Tax Expense (Benefit) 68,231,000 USD +48.4%
Net Income (Loss) Attributable to Parent 217,564,000 USD +52.4%
Earnings Per Share, Basic 1 USD/shares +44.4%
Earnings Per Share, Diluted 1 USD/shares +43.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 689,892,000 USD +56%
Accounts Receivable, after Allowance for Credit Loss, Current 106,409,000 USD +82.6%
Inventory, Net 28,029,000 USD +40%
Assets, Current 852,453,000 USD +58.2%
Deferred Income Tax Assets, Net 48,256,000 USD -0.45%
Property, Plant and Equipment, Net 1,077,000 USD -22%
Operating Lease, Right-of-Use Asset 2,010,000 USD -12.6%
Assets 1,051,602,000 USD +36.2%
Accounts Payable, Current 9,096,000 USD -21.3%
Employee-related Liabilities, Current 10,573,000 USD +31.9%
Accrued Liabilities, Current 119,639,000 USD +27.5%
Liabilities, Current 128,735,000 USD +22.1%
Operating Lease, Liability, Noncurrent 2,461,000 USD -14.8%
Other Liabilities, Noncurrent 161,000 USD -94.2%
Liabilities 131,357,000 USD +18.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD
Retained Earnings (Accumulated Deficit) 446,789,000 USD +94.9%
Stockholders' Equity Attributable to Parent 920,245,000 USD +39.2%
Liabilities and Equity 1,051,602,000 USD +36.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 60,043,000 USD +88.1%
Net Cash Provided by (Used in) Financing Activities 3,060,000 USD -97.8%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 200,000,000 shares 0%
Common Stock, Shares, Issued 123,264,583 shares +3.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 689,892,000 USD +56%
Interest Paid, Excluding Capitalized Interest, Operating Activities 103,000 USD +58.5%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 49,058,000 USD +28%
Operating Lease, Liability 2,889,000 USD -12%
Depreciation 115,000 USD +33.7%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 217,564,000 USD +52.4%
Lessee, Operating Lease, Liability, to be Paid 3,285,000 USD -14%
Operating Lease, Liability, Current 428,000 USD +8.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 570,000 USD +3.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 553,000 USD +3%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 396,000 USD -26.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 587,000 USD +3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 605,000 USD +3.1%
Operating Lease, Payments 132,000 USD +2.3%
Additional Paid in Capital 473,333,000 USD +9.7%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 9,345,000 USD +0.01%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%